![Stephen L. Bandak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen L. Bandak
Directeur/Membre du Conseil chez
Hapten Sciences, Inc.
Profil
Stephen L.
Bandak is currently the Director at Hapten Sciences, Inc. and a Member of The Royal College of Physicians since 1977.
He was previously the Vice President-Medical & Regulatory Affairs at Novavax, Inc. and the Chief Medical Officer at Synosia Therapeutics AG from 2007 to 2011, at Biotie Therapies Oy from 2011 to 2016, and at Synosia Therapeutics, Inc. from 2007 to 2011.
Postes actifs de Stephen L. Bandak
| Sociétés | Poste | Début |
|---|---|---|
Hapten Sciences, Inc.
 Hapten Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures molecule products | Directeur/Membre du Conseil | - |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1977 |
Anciens postes connus de Stephen L. Bandak
| Sociétés | Poste | Fin |
|---|---|---|
| BIOTIE THERAPIES CORP | Directeur Technique/Scientifique/R&D | 30/06/2016 |
Synosia Therapeutics AG
 Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of psychiatry and neurology diseases | Directeur Technique/Scientifique/R&D | 01/01/2011 |
Synosia Therapeutics, Inc.
 Synosia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops products for unmet medical needs in psychiatry and neurology | Directeur Technique/Scientifique/R&D | 01/01/2011 |
| NOVAVAX, INC. | Directeur Technique/Scientifique/R&D | 19/09/2011 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Synosia Therapeutics AG
Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of psychiatry and neurology diseases | Health Technology |
Hapten Sciences, Inc.
Hapten Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures molecule products | Health Technology |
Biotie Therapies Oy
 Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synosia Therapeutics, Inc.
Synosia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops products for unmet medical needs in psychiatry and neurology | Health Technology |
